Cargando…

Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer

The interplay between cellular stress and immune response can be variable and sometimes contradictory. The mechanisms by which stress-activated pathways regulate the inflammatory response to a pathogen, in autoimmunity or during cancer progression remain unclear in many aspects, despite our recent k...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilotta, Maria Teresa, Petillo, Sara, Santoni, Angela, Cippitelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670053/
https://www.ncbi.nlm.nih.gov/pubmed/33224146
http://dx.doi.org/10.3389/fimmu.2020.584303
_version_ 1783610661196005376
author Bilotta, Maria Teresa
Petillo, Sara
Santoni, Angela
Cippitelli, Marco
author_facet Bilotta, Maria Teresa
Petillo, Sara
Santoni, Angela
Cippitelli, Marco
author_sort Bilotta, Maria Teresa
collection PubMed
description The interplay between cellular stress and immune response can be variable and sometimes contradictory. The mechanisms by which stress-activated pathways regulate the inflammatory response to a pathogen, in autoimmunity or during cancer progression remain unclear in many aspects, despite our recent knowledge of the signalling and transcriptional pathways involved in these diseases. In this context, over the last decade many studies demonstrated that cholesterol metabolism is an important checkpoint for immune homeostasis and cancer progression. Indeed, cholesterol is actively metabolized and can regulate, through its mobilization and/or production of active derivatives, many aspects of immunity and inflammation. Moreover, accumulation of cholesterol has been described in cancer cells, indicating metabolic addiction. The nuclear receptors liver-X-receptors (LXRs) are important regulators of intracellular cholesterol and lipids homeostasis. They have also key regulatory roles in immune response, as they can regulate inflammation, innate and adaptive immunity. Moreover, activation of LXRs has been reported to affect the proliferation and survival of different cancer cell types that show altered metabolic pathways and accumulation of cholesterol. In this minireview we will give an overview of the recent understandings about the mechanisms through which LXRs regulate inflammation, autoimmunity, and cancer, and the therapeutic potential for future treatment of these diseases through modulation of cholesterol metabolism.
format Online
Article
Text
id pubmed-7670053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76700532020-11-20 Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer Bilotta, Maria Teresa Petillo, Sara Santoni, Angela Cippitelli, Marco Front Immunol Immunology The interplay between cellular stress and immune response can be variable and sometimes contradictory. The mechanisms by which stress-activated pathways regulate the inflammatory response to a pathogen, in autoimmunity or during cancer progression remain unclear in many aspects, despite our recent knowledge of the signalling and transcriptional pathways involved in these diseases. In this context, over the last decade many studies demonstrated that cholesterol metabolism is an important checkpoint for immune homeostasis and cancer progression. Indeed, cholesterol is actively metabolized and can regulate, through its mobilization and/or production of active derivatives, many aspects of immunity and inflammation. Moreover, accumulation of cholesterol has been described in cancer cells, indicating metabolic addiction. The nuclear receptors liver-X-receptors (LXRs) are important regulators of intracellular cholesterol and lipids homeostasis. They have also key regulatory roles in immune response, as they can regulate inflammation, innate and adaptive immunity. Moreover, activation of LXRs has been reported to affect the proliferation and survival of different cancer cell types that show altered metabolic pathways and accumulation of cholesterol. In this minireview we will give an overview of the recent understandings about the mechanisms through which LXRs regulate inflammation, autoimmunity, and cancer, and the therapeutic potential for future treatment of these diseases through modulation of cholesterol metabolism. Frontiers Media S.A. 2020-11-03 /pmc/articles/PMC7670053/ /pubmed/33224146 http://dx.doi.org/10.3389/fimmu.2020.584303 Text en Copyright © 2020 Bilotta, Petillo, Santoni and Cippitelli http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bilotta, Maria Teresa
Petillo, Sara
Santoni, Angela
Cippitelli, Marco
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title_full Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title_fullStr Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title_full_unstemmed Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title_short Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
title_sort liver x receptors: regulators of cholesterol metabolism, inflammation, autoimmunity, and cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670053/
https://www.ncbi.nlm.nih.gov/pubmed/33224146
http://dx.doi.org/10.3389/fimmu.2020.584303
work_keys_str_mv AT bilottamariateresa liverxreceptorsregulatorsofcholesterolmetabolisminflammationautoimmunityandcancer
AT petillosara liverxreceptorsregulatorsofcholesterolmetabolisminflammationautoimmunityandcancer
AT santoniangela liverxreceptorsregulatorsofcholesterolmetabolisminflammationautoimmunityandcancer
AT cippitellimarco liverxreceptorsregulatorsofcholesterolmetabolisminflammationautoimmunityandcancer